Amgen Inc. AMGN

Clinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2026 | Benchmark More Than 1,800 Biopharma Deals with Various Indexes

GlobeNewswire Inc. · 21h ago

Landmark ECOG-ACRIN ENDURANCE Study Co-Authored by International Myeloma Foundation Leaders Provides Evidence for Optimal Duration of Maintenance Therapy

GlobeNewswire Inc. · 2d ago

Autoimmune Disease Therapeutics Market Size to Reach USD 137.85 Billion by 2035 as Biologics and Precision Medicine Drive Growth | SNS Insider

GlobeNewswire Inc. · 2d ago

Biotech ETFs: How Do FBT and IBB Match Up on Cost, Structure, and Performance?

The Motley Fool · 5d ago

BBH vs. XPH: Which Healthcare ETF Is Better for Beginners?

The Motley Fool · 9d ago

The Dow Couldn't Keep Up With Chip Stocks on Monday

The Motley Fool · 11d ago

Alphabet Just Joined the Dow Jones Industrial Average. 3 Dow Dividend Stocks to Buy Now.

The Motley Fool · 17d ago

Amgen vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?

The Motley Fool · 24d ago

Cutaneous Lupus Erythematosus Market to Expand at a CAGR of 8% During the Forecast Period (2026–2036) Amid Emerging Therapies and Increasing Healthcare Investments | DelveInsight

GlobeNewswire Inc. · 25d ago

Amgen Seeks FDA Hearing To Challenge Proposed Tavneos Withdrawal

Benzinga · 35d ago

AbbVie Reports Promising New Clinical Updates. Here's What It Means for the Company's Dividend.

The Motley Fool · 35d ago

President Trump Loaded Up on Eli Lilly in Q1. Should You Buy the Obesity Drug Stock Too?

The Motley Fool · 51d ago

AI Bots Crashed $10K in 2 Weeks While This ’Beat-the-Bot’ Divvie Sails Higher

Investing.com · 51d ago

My Personal Plan to Turn Market Chaos Into 300%+ Growth

Investing.com · 52d ago

CytomX Therapeutics to Present at Upcoming June Investor Conferences

GlobeNewswire Inc. · 57d ago

Eli Lilly Stock: Next Stop $2,000?

The Motley Fool · 60d ago

Amgen Japanese Partner Urges Caution On Tavneos Use

Benzinga · 60d ago

Oligonucleotides Clinical Trial Drug Development Pipeline Expands with Contributions from 200+ Key Companies | DelveInsight

GlobeNewswire Inc. · 64d ago

Global Colorectal Cancer Diagnostics and Therapeutics Market Anticipates Impressive Growth Trajectory at a CAGR of ~9% by 2034 | DelveInsight

GlobeNewswire Inc. · 65d ago

Wall Street's Cardiac Bet: Where Diagnostics Meet the Money

Benzinga · 66d ago

Global Personalized Medicine to Transform Modern Healthcare and Cross USD 1 Trillion by 2034 | DelveInsight

GlobeNewswire Inc. · 67d ago

2 Dividend Stocks to Double Up On Right Now

The Motley Fool · 70d ago

Stock Market Today: Apple Earnings Power S&P 500, Nasdaq To Records; Trump Hits EU

Benzinga · 77d ago

FDA Announces Major Steps to Implement Real-Time Clinical Trials

GlobeNewswire Inc. · 80d ago

Mag 7 Earnings Bonanza, Fed Await Stocks at Record Highs: What to Expect

Investing.com · 81d ago